During the past grant cycle, the Neuroscience Core consisted of two components: Brain Imaging and Cellular Morphology. These components were related by their support of Research Affiliates studying the neurobiology of neurodevelopmental and neurodegenerative disorders. However, as new technologies and investigators were assimilated into both components, it became clear that these two components had divergently expanded to a point that justified splitting into two separate Cores. The now separate Cellular Morphology Core has been growing extensively during the past grant cycle, acquiring new equipment, incorporafing new technologies, and assisting a large number of new Research Affiliates. Advances in the molecular genetics of human disease in combination with burgeoning new technologies in mammalian genetic engineering have resulted in a large number of novel cell, tissue, and animal models of human disease. This has lead to increased demand for the availability of research methodologies needed to carefully characterize these new models and provide quantifiable readouts of phenotypes that can be employed to study the efficacy of therapeufic interventions in pre-clinical trials.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Center Core Grants (P30)
Project #
5P30HD002274-46
Application #
8508968
Study Section
Special Emphasis Panel (ZHD1-MRG-C)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
46
Fiscal Year
2013
Total Cost
$146,770
Indirect Cost
$83,072
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Su, Z; Wang, X; Gao, X et al. (2014) Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J Intern Med 276:470-85
Mason, Amanda G; Tome, Stephanie; Simard, Jodie P et al. (2014) Expression levels of DNA replication and repair genes predict regional somatic repeat instability in the brain but are not altered by polyglutamine disease protein expression or age. Hum Mol Genet 23:1606-18
Wang, Wenbin; Pan, Yung-Wei; Zou, Junhui et al. (2014) Genetic activation of ERK5 MAP kinase enhances adult neurogenesis and extends hippocampus-dependent long-term memory. J Neurosci 34:2130-47
Careaga, Milo; Noyon, Tamanna; Basuta, Kirin et al. (2014) Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome. J Neuroinflammation 11:110
Basuta, K; Lozano, R; Schneider, A et al. (2014) A family with two female siblings with compound heterozygous FMR1 premutation alleles. Clin Genet 85:458-63
Su, Wei; Hopkins, Stephanie; Nesser, Nicole K et al. (2014) The p53 transcription factor modulates microglia behavior through microRNA-dependent regulation of c-Maf. J Immunol 192:358-66
Tassone, Flora (2014) Newborn screening for fragile X syndrome. JAMA Neurol 71:355-9
Cooke, Cheryl L; Bowie, Bonnie H; Carrère, Sybil (2014) Perceived discrimination and children's mental health symptoms. ANS Adv Nurs Sci 37:299-314
Vanderhoeven, Jeroen P; Bierle, Craig J; Kapur, Raj P et al. (2014) Group B streptococcal infection of the choriodecidua induces dysfunction of the cytokeratin network in amniotic epithelium: a pathway to membrane weakening. PLoS Pathog 10:e1003920
Naydenov, Alipi V; Horne, Eric A; Cheah, Christine S et al. (2014) ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice. Neuron 83:361-71

Showing the most recent 10 out of 140 publications